Switzerland

On October 13, 2025, ADC Therapeutics SA (NYSE: ADCT), a commercial-stage biotechnology company headquartered in Switzerland, announced a USD 60 m private investment in public equity (“PIPE”) financing. In the PIPE, 11.3 m common shares and pre-funded warrants to purchase 3.8 m common shares were sold. The PIPE is led by TCGX and includes participation from Redmile Group and other existing investors. The Homburger team was led by Daniel Häusermann (Corporate / M&A, Capital Markets) and included Bianca Nedwed (Corporate / M&A, Capital Markets) as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]  

On October 8, 2025, ABB Ltd announced it has signed an agreement to divest its robotics division to SoftBank Group Corp. for an enterprise value of USD 5.375 bn. ABB’s robotics business is one of the world’s leading robotics suppliers with a global customer base and approximately 7,000 employees. The sale is subject to a carve-out through a multi-jurisdictional reorganization which will conclude prior to closing. Completion is also subject to the receipt of customary regulatory clearances. Homburger acts as Swiss counsel to ABB. The Homburger team includes Claude Lambert, Andreas Müller, Anna Peter, Estelle Piccard, Claudine Schär, Simone Schmid and Luca Ellenberger (all Corporate / M&A), Reto Heuberger, Peter Müller and Juliette Buob (all Tax) as well as Andri Hess and Noëmie Beck-Schär (both IP/IT). Contact Wanda Schweda / Marketing / [email protected]  

On October 13, 2025, Allwyn International AG and OPAP S.A. announced that their respective boards of directors have approved the business combination of Allwyn and OPAP through an all-share transaction that values the resulting entity at an equity value of EUR 16 bn. The Combined Company will be renamed Allwyn. It will remain listed on the Main Market of the Athens Stock Exchange and intends to pursue an additional listing on another leading international exchange such as London or in New York following closing. The transaction will bring together two leading gaming operators, creating the second largest listed gaming entertainment company globally, with multiple diverse, fast-growing and market-leading positions across Europe, the United States and other international markets. The Homburger team includes Anna Peter, Flavio Romerio and Bianca Nedwed (all Corporate / M&A). Contact Wanda Schweda / Marketing / [email protected]

On October 10, 2025, SIX-listed Idorsia Ltd announced the launch of an accelerated bookbuilding offering, which led to the successful placement of 16.4 m shares at an offer price of CHF 4.00 per offered share, raising aggregate gross proceeds of approximately CHF 65.6 m. The offering was conducted by way of (i) a placement to professional investors in Switzerland or in any other circumstances relying on an exemption from the obligation to publish a prospectus under the Swiss Financial Services Act, (ii) private placements in certain jurisdictions outside of Switzerland and the United States, and (iii) private placements within the United States to qualified institutional buyers in reliance on Rule 144A under the U.S. Securities Act. Idorsia Ltd intends to use the net proceeds from the offering to accelerate QUVIVIQ’s commercial trajectory, to advance its pipeline, to strengthen its balance sheet, and for general corporate purposes. J.P. Morgan and UBS are acting as Joint Bookrunners and Global Coordinators, and H.C. Wainwright & Co. is acting as Lead Manager in connection with the offering. The Homburger team was led by Frank Gerhard (Corporate / M&A) and included Lorenzo Togni (Capital Markets), Estelle Piccard, Lucas Forrer, Anina Preusker and Jannis Zafeirakos (all Corporate / M&A) as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]